Exchange Announcement • 22 May 2026 17:17
Exchange Announcement • 26 Apr 2026 18:59
Exchange Announcement • 23 Apr 2026 16:58
Exchange Announcement • 23 Apr 2026 16:57
Exchange Announcement • 23 Apr 2026 16:56
𝛼SK or SearchENTITY
Brii Biosciences (2137 HK)
Brii Biosciences (2137 HK)
35
Analysis
Health Care • China
Brii Biosciences is a biotechnology company focused on developing therapies for infectious and central nervous system diseases. The company has a broad pipeline of therapeutic candidates, with lead programs targeting hepatitis B virus (HBV) infection, and also develops treatments for multi-drug resistant bacterial infections. Brii Biosciences is headquartered in Beijing, China, and was founded in 2017.
morex